https://www.biopharma-reporter.com/Article/2023/02/22/daiichi-sankyo-to-establish-japan-s-first-mrna-production-facility
0
0
44 words
0
Comments
Daiichi Sankyo is kitting out a plant, based near Tokyo in Kitamoto, with equipment to enable the production of an mRNA vaccine against COVID-19, according to a Nikkei Asia report.
You are the first to view
Create an account or login to join the discussion